Literature DB >> 16982492

Selectin polymorphisms and perinatal morbidity in low-birthweight infants.

László Derzbach1, Géza Bokodi, András Treszl, Barna Vásárhelyi, Andras Nobilis, János Rigó.   

Abstract

BACKGROUND: Studies have shown an association between altered expression of selectins and premature birth, early sepsis and bronchopulmonary dysplasia. AIM: To investigate the possible link between functional polymorphisms of the E-, P- and L-selectin genes and perinatal morbidity.
METHODS: We compared the genotype distribution of the E-selectin Ser128Arg, P-selectin Thr715Pro and L-selectin Pro213Ser polymorphisms in 125 low-birthweight singleton infants with those of 156 healthy term neonates. We also analysed the association of genotype with risk of sepsis and bronchopulmonary dysplasia.
RESULTS: We found no association between E-selectin or P-selectin polymorphisms and premature birth, nor did we find any association between E-selectin or P-selectin and early postnatal sepsis or bronchopulmonary dysplasia. Carriers of the 213Ser L-selectin allele were found to be more prevalent in low-birthweight infants, particularly in those with bronchopulmonary dysplasia. We found no association between the L-selectin polymorphism and early postnatal sepsis.
CONCLUSION: Our results underline the importance of L-selectin in perinatal pathology, but further studies are needed to evaluate the alteration of L-selectin levels in carriers of the 213Ser allele and their possible contribution to premature birth and bronchopulmonary dysplasia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982492     DOI: 10.1080/08035250600575404

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  6 in total

Review 1.  The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung disease.

Authors:  Carlo Dani; Chiara Poggi
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

Review 2.  Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?

Authors:  Clyde J Wright; Haresh Kirpalani
Journal:  Pediatrics       Date:  2011-06-06       Impact factor: 7.124

Review 3.  Progress in understanding the genetics of bronchopulmonary dysplasia.

Authors:  Gary M Shaw; Hugh M O'Brodovich
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

4.  Expression of lymphocyte activation markers of preterm neonates is associated with perinatal complications.

Authors:  Florentina Sava; Gergely Toldi; András Treszl; Júlia Hajdú; Ágnes Harmath; Tivadar Tulassay; Barna Vásárhelyi
Journal:  BMC Immunol       Date:  2016-06-21       Impact factor: 3.615

5.  Verification of immunology-related genetic associations in BPD supports ABCA3 and five other genes.

Authors:  Felix Blume; Holger Kirsten; Peter Ahnert; Trinad Chakraborty; Arnd Gross; Katrin Horn; Mohammad Reza Toliat; Peter Nürnberg; Eva-Maria Westenfelder; Wolfgang Goepel; Markus Scholz
Journal:  Pediatr Res       Date:  2021-08-31       Impact factor: 3.953

Review 6.  Antioxidant strategies and respiratory disease of the preterm newborn: an update.

Authors:  Chiara Poggi; Carlo Dani
Journal:  Oxid Med Cell Longev       Date:  2014-04-07       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.